Test Price
2,800 AED✅ Home Collection Available
NTNG1 Gene Sequencing Test for Autism Spectrum Disorder (NGS) in UAE | 2,800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity delivered through ISO 15189 and ISO 9001:2015 accredited processing protocols.
Premium Logistics: VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM for peripheral whole blood specimens.
Clinical Guidance: Post-test telephone genetic counseling provided in English by a board-certified Consultant Medical Geneticist.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The NTNG1 gene sequencing test utilises Next‑Generation Sequencing (NGS) to identify pathogenic and likely pathogenic variants in the NTNG1 gene, which has been strongly associated with autism spectrum disorder (ASD). This targeted single‑gene analysis provides precise diagnostic data to guide clinical management, early intervention planning, and genetic counseling for affected individuals and their families.
| Feature | NTNG1 NGS Test | Standard Chromosomal Microarray |
|---|---|---|
| Precision | Targeted single‑gene & variant analysis | Whole‑genome copy number variation detection |
| Methodology | NGS (Next‑Generation Sequencing) | Array‑based hybridisation |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks |
Physician Insight & Safety Protocols
“In my practice, I have seen how genetic clarity can transform the journey for families navigating autism spectrum disorder. The NTNG1 gene test provides targeted molecular evidence that, when integrated with thorough developmental assessment and family history, enables more precise diagnosis and personalised intervention strategies. Every result must be interpreted within the full clinical context, and no therapeutic adjustments should ever be made without direct medical supervision.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
⚠ Medication Safety Advisory
Never discontinue prescribed medications, behavioural therapies, or educational interventions without first consulting the managing physician. Abrupt changes may disrupt clinical stability and negatively affect developmental progress.
🚨 Exclusion Criteria & Emergency Red Flags
- Known pathogenic variant outside the NTNG1 coding region requires a broader panel or whole‑exome sequencing approach.
- Non‑consenting minors — guardian consent is mandatory per UAE Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields.
- If the child demonstrates acute speech regression, sudden loss of developmental milestones, or new‑onset seizures, seek immediate emergency medical care.
Patient FAQ & Clinical Guidance
1. What does the NTNG1 gene test detect?
The test identifies pathogenic or likely pathogenic variants in the NTNG1 gene that are strongly linked to autism spectrum disorder. These variants can confirm a genetic aetiology, inform recurrence risk, and guide personalised intervention plans.
2. Who should consider this genetic test?
Children presenting with developmental delays, social communication deficits, repetitive behavioural patterns consistent with ASD, and those with a positive family history of autism or unexplained neurodevelopmental disorders are appropriate candidates.
3. How long until I receive the results?
Results are typically reported within 3 to 4 weeks from sample receipt at the laboratory. A telephonic genetic counseling session is provided immediately upon report release to explain findings and discuss next steps.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
All genetic data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
DNA Labs UAE holds DHA Facility License No. 1143 and is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139), ensuring rigorous quality management across every stage of the testing process.
Clinical & Logistical Metadata
| Test Name | NTNG1 Gene Sequencing (NGS) for Autism Spectrum Disorder |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM |
| Methodology Used | Next‑Generation Sequencing (NGS) – Targeted single‑gene analysis |
| ICD-10-CM Code | F84.0 |
| LOINC Code | 92821-0 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians